Fundraising Fox

ChromaCode

Carlsbad, US · Founded 2012 · Delaware corporation · 8 known investors

chromacode.com ↗

ChromaCode develops a High-Definition PCR (HDPCR) multiplexing platform that enables genomic solutions for oncology and precision medicine, offering faster results and cost-effective workflows through automated interpretation and cloud-based software.

AI & Machine LearningBiotechHealthtechMedical Devicesin /chromacode-inc.@chromacodeinc

Founders & leadership

AR
Aditya RajagopalDirector
PF
Paul FlookExecutive Officer, Director
JC
James C. BlairDirector
GJ
Gregory J. GoschExecutive Officer, Director
AS
Axel SchererDirector
AG
Alexander G. DickinsonDirector
LR
Lynne RollinsExecutive Officer
JK
Justin KleinDirector

Investors · 8

Adjuvant CapitalNew York · $10M – $25M
Global BrainTokyo · $100K – $184M
Moore Venture PartnersSan Diego
Windham Capital PartnersNew York
Windham Venture PartnersNew York · $1M – $5M
Domain AssociatesreportedPrinceton · $200K – $15M
Northpond VenturesreportedBethesda · $100K – $5M
Vensana Capitalreported · 2 sourcesMinneapolisvia Justin Klein · board

Reported raises · per SEC filings

Form D private placements
▶$3.8MraisedFeb 2025 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Aditya RajagopalDirector
  • Paul FlookExecutive Officer, Director
  • Justin KleinDirector
Offering amount
$5M
Amount sold
$3.8M
First sale
Jan 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$38MraisedFeb 2023 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mark McDonoughExecutive Officer, Director
  • Justin KleinDirector
  • Pat SmerkersDirector
  • Alexander G. DickinsonDirector
  • Kevin O'BoyleDirector
  • Carol GallagherDirector
  • Aditya RajagopalDirector
  • Jenny YipDirector
Offering amount
$43M
Amount sold
$38M
First sale
Feb 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$38.6MraisedDec 2020 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jenny YipDirector
  • Lynne RollinsExecutive Officer
  • Pat SmerkersDirector
  • Carol GallagherDirector
  • James C. BlairDirector
  • Alexander G. DickinsonDirector
  • Aditya RajagopalDirector
  • Gregory J. GoschExecutive Officer, Director
Offering amount
$41.2M
Amount sold
$38.6M
First sale
Aug 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.8MraisedApr 2019 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James C. BlairDirector
  • Carol GallagherDirector
  • Alexander G. DickinsonDirector
  • Gregory J. GoschExecutive Officer, Director
  • Aditya RajagopalDirector
  • Lynne RollinsExecutive Officer
Offering amount
$3.5M
Amount sold
$1.8M
First sale
Apr 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12MraisedApr 2017 · 9 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • James C. BlairDirector
  • Gregory J. GoschExecutive Officer, Director
  • Peter Justin KleinDirector
  • Axel SchererDirector
  • Alexander G. DickinsonDirector
  • Lynne RollinsExecutive Officer
Offering amount
$12.1M
Amount sold
$12M
First sale
Apr 2017
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news